Franklin K2 Alternative Strategies Fund W (Acc)

Reference Data

ISIN LU1309513338
Valor Number 30192815
Bloomberg Global ID
Fund Name Franklin K2 Alternative Strategies Fund W (Acc)
Fund Provider Franklin Templeton Switzerland Ltd Zürich, Switzerland
Phone: +41 44 217 81 81
Web: www.franklintempleton.ch
Fund Provider Franklin Templeton Switzerland Ltd
Representative in Switzerland Franklin Templeton Switzerland AG
Zürich
Distributor(s) FRANKLIN TEMPLETON SWITZERLAND LTD
Zürich
Asset Class Other Funds
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The Fund's investment objective is to seek capital appreciation with lower volatility relative to the broad equity markets.
Peculiarities

Fund Prices

Current Price * 13.21 USD 07.11.2024
Previous Price * 13.18 USD 06.11.2024
52 Week High * 13.23 USD 20.10.2024
52 Week Low * 11.76 USD 09.11.2023
NAV * 13.21 USD 07.11.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 657,976,860
Unit/Share Assets *** 23,890,355
Trading Information SIX

Performance

YTD Performance +9.72% 29.12.2023
07.11.2024
YTD Performance (in CHF) +13.75% 29.12.2023
07.11.2024
1 month +0.46% 07.10.2024
07.11.2024
3 months +4.34% 07.08.2024
07.11.2024
6 months +3.77% 07.05.2024
07.11.2024
1 year +11.95% 07.11.2023
07.11.2024
2 years +14.67% 07.11.2022
07.11.2024
3 years +3.88% 08.11.2021
07.11.2024
5 years +15.67% 07.11.2019
07.11.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Franklin K2 ActusRay Ptnrs Eurp Alp XEUR 6.61%
United States Treasury Bills 3.24%
United States Treasury Bills 2.16%
Franklin K2 ActusRay Ptnrs Eurp Alp YEUR 1.69%
Constellation Energy Corp 0.88%
GE Vernova Inc 0.80%
MasTec Inc 0.61%
3M Co 0.54%
Bristol-Myers Squibb Co 0.50%
Eli Lilly and Co 0.44%
Last data update 30.09.2024

Cost / Risk

TER *** 1.92%
TER date *** 31.07.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.75%
Ongoing Charges *** 1.75%
SRRI ***
SRRI date *** 31.10.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)